Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Nitz, U.; Gluz, O.; Huober, J.; Kreipe, H. H.; Kates, R. E.; Hartmann, A.; Erber, R.; Scholz, M.; Lisboa, B.; Mohrmann, S.; Moebus, V.; Augustin, D.; Hoffmann, G.; Weiss, E.; Boehmer, S.; Kreienberg, R.; Du Bois, A.; Sattler, D.; Thomssen, C.; Kiechle, M.; Jaenicke, F.; Wallwiener, D.; Harbeck, N.; Kuhn, W.

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Author:

Nitz, U.; Gluz, O.; Huober, J.; Kreipe, H. H.; Kates, R. E.; Hartmann, A.; Erber, R.; Scholz, M.; Lisboa, B.; Mohrmann, S.; Moebus, V.; Augustin, D.; Hoffmann, G.; Weiss, E.; Boehmer, S.; Kreienberg, R.; Du Bois, A.; Sattler, D.; Thomssen, C.; Kiechle, M.; Jaenicke, F.; Wallwiener, D.; Harbeck, N.; Kuhn, W.

Tübinger Autor(en):

Huober, Jens
Wallwiener, Diethelm

Published in:

Annals of Oncology (2014), Bd. 25, H. 8, S. 1551-1557

Verlagsangabe:

Oxford Univ Press

Language:

English

Full text:

http://dx.doi.org/10.1093/annonc/mdu186

ISSN:

0923-7534